๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

โœ Scribed by Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papadimitrakopoulou; Gary Clayman; J. Jack Lee; K. Kian Ang; Scott M. Lippman; Waun Ki Hong

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
97 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Paclitaxel, cisplatin, and 5-fluorouraci
Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
โœ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 1 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Phase II study of carboplatin and liposo
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
โœ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 2 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti